Autologous dinitrophenol vaccine (AVAX/Thomas Jefferson University)

N/A

Report date: 2022/11/27 13:48:36

Base Information

Drug NameAutologous dinitrophenol vaccine (AVAX/Thomas Jefferson University)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOvarian NeoplasmsCarcinoma, Renal CellMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAvax Technologies IncThomas Jefferson University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThomas Jefferson UniversityAvax Technologies Inc
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsCarcinoma, Renal CellMelanoma

Other Information

ATC CodeN/A
Related LinksN/A